Valuation: Square Pharmaceuticals PLC.

Market Cap 196B 1.59B 1.39B 1.28B 1.19B 2.25B 152B 2.29B 15.33B 6.02B 74.74B 5.97B 5.84B 257B P/E 2026 *
7.38x
P/E 2027 * 6.4x
Enterprise Value 196B 1.59B 1.39B 1.28B 1.19B 2.25B 152B 2.29B 15.33B 6.02B 74.74B 5.97B 5.84B 257B EV / Sales 2026 *
2.3x
EV / Sales 2027 * 2.06x
Free-Float
55.9%
Yield 2026 *
6.33%
Yield 2027 * 7.92%
1 day-0.76%
1 week-0.27%
Current month-1.34%
1 month+2.46%
3 months+3.66%
6 months+9.30%
Current year+11.28%
1 week 220.4
Extreme 220.4
224.4
1 month 215.9
Extreme 215.9
228
Current year 198.1
Extreme 198.1
236
1 year 198
Extreme 198
236
3 years 197.2
Extreme 197.2
249.8
5 years 197.2
Extreme 197.2
251.9
10 years 149.05
Extreme 149.0476
278.67
Manager TitleAgeSince
Chief Executive Officer - 1994-12-31
Director of Finance/CFO - -
Compliance Officer - -
Director TitleAgeSince
Chairman - 2011-12-31
Director/Board Member - 1979-12-31
Director/Board Member - 2006-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.76%-0.27%+5.34%+5.34% 1.59B
-2.33%-2.09%+49.88%+170.51% 1,060B
-0.82%-2.30%+63.79%+62.00% 619B
-0.73%-4.98%+28.91%+82.99% 438B
+0.33%-1.17%+31.07%+27.09% 333B
-0.02%-2.85%+29.15%+45.24% 282B
-3.89%-11.22%+22.81%+27.30% 267B
+0.66%-1.42%-26.59%-37.71% 218B
-0.06%-2.88%+23.07%+62.33% 196B
-3.72%-1.10%+18.41%+70.56% 161B
Average -1.13%-2.98%+24.58%+51.56% 357.55B
Weighted average by Cap. -1.31%-2.96%+36.74%+83.87%

Financials

2026 *2027 *
Net sales 85.11B 691M 605M 558M 515M 977M 65.92B 994M 6.66B 2.62B 32.47B 2.59B 2.54B 112B 95.26B 774M 677M 624M 576M 1.09B 73.78B 1.11B 7.46B 2.93B 36.34B 2.9B 2.84B 125B
Net income 26.6B 216M 189M 174M 161M 305M 20.6B 311M 2.08B 818M 10.15B 811M 793M 34.89B 30.69B 249M 218M 201M 186M 352M 23.77B 358M 2.4B 943M 11.71B 936M 915M 40.25B
Net Debt - -
Logo Square Pharmaceuticals PLC.
Square Pharmaceuticals PLC is a Bangladesh-based pharmaceutical manufacturer and exporter. Its core business activities include the manufacture and distribution of generic pharmaceutical products, basic chemical products, and animal health products. The Company operates in one segment: the business of developing, manufacturing, and marketing drugs for healthcare for all living species. It is also involved in the distribution of crop care products. The Company offers its products in several categories, including products listed by trade name, by therapeutic class, and by generic name. In addition to conventional pharmaceuticals, it also offers products under the Herbal & Nutraceuticals category, as well as AgroVet & Pesticides, which cover veterinary and agricultural chemical products. The Company’s manufacturing facilities are located in Pabna and Dhaka, Bangladesh. Its subsidiaries include Square Lifesciences Ltd., Square Pharmaceuticals Kenya EPZ Ltd., and Samson Pharma Inc.
Employees
15,937
Date Price Change Volume
26-07-09 BDT 221.00 -0.76% 348,846
26-07-08 BDT 222.70 -0.22% 244,988
26-07-07 BDT 223.20 -0.18% 430,797
26-07-06 BDT 223.60 +0.58% 530,925
26-07-05 BDT 222.30 +0.32% 420,016
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
221.00BDT
Average target price
352.20BDT
Spread / Average Target
+59.37%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SQURPHARMA Stock